StockData
Aesthetic Medical International Holdings Group Ltd logo

Aesthetic Medical International Holdings Group Ltd (PAIYY) stock analysis

PAIYYOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 23, 2026Score 2/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026

StockData Score

Prices as of Nov 13, 2026How the score works

Value0Growth1Performance1Health0Dividend0

Weak2 of 30 checks passed

Aesthetic Medical International passes 2 of the 30 checks behind our score; 22 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
1/6
Past performance
1/6
Financial health
0/6
Dividend
0/6

What stands out

  • Gross margin improving

    Gross margin was 46.2% over the last twelve months, against 44.7% a year earlier.

  • Net margin above its 5-year average

    Net margin was -7.4% over the last twelve months, against a 5-year average of -23.5%.

What to watch

  • Revenue growing under 10% a year

    Revenue grew 2.6% a year over the last three fiscal years, short of the 10% we look for.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals -8.5% of total debt; we look for at least 20%.

  • Growing slower than the industry

    Revenue grew -4.3% over the last twelve months; the Health Services median is 2.0%.

  • Return on equity below the industry

    Aesthetic Medical International's return on equity of -1082% is below the Health Services median of 3.6%.

Valuation0/6

  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B against the industry

    Needs positive book value.

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth1/6

  • Revenue growing under 10% a year

    Revenue grew 2.6% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew -4.3% over the last twelve months; the Health Services median is 2.0%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin improving

    Gross margin was 46.2% over the last twelve months, against 44.7% a year earlier.

Past performance1/6

  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity below the industry

    Aesthetic Medical International's return on equity of -1082% is below the Health Services median of 3.6%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin above its 5-year average

    Net margin was -7.4% over the last twelve months, against a 5-year average of -23.5%.

  • Net margin below the industry

    Aesthetic Medical International's net margin of -7.4% is below the Health Services median of -1.0%.

Financial health0/6

  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals -8.5% of total debt; we look for at least 20%.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term liquidity

    The balance sheet is not split into current and non-current items.

  • Bankruptcy risk (Altman Z)

    Needs market value, working capital and retained earnings.

Dividend0/6

  • No dividend

    Aesthetic Medical International has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for Aesthetic Medical International. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Margins

Share of revenue, fiscal years 2017 to 2025

Gross margin

46.2%−14.2 pts over 5 years

Net margin

-7.4%+18.7 pts over 5 years

See a number that looks wrong?